JP2022547711A5 - - Google Patents
Info
- Publication number
- JP2022547711A5 JP2022547711A5 JP2022516270A JP2022516270A JP2022547711A5 JP 2022547711 A5 JP2022547711 A5 JP 2022547711A5 JP 2022516270 A JP2022516270 A JP 2022516270A JP 2022516270 A JP2022516270 A JP 2022516270A JP 2022547711 A5 JP2022547711 A5 JP 2022547711A5
- Authority
- JP
- Japan
- Prior art keywords
- approximately
- compound
- administration
- use according
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962900298P | 2019-09-13 | 2019-09-13 | |
| US62/900,298 | 2019-09-13 | ||
| US202063031686P | 2020-05-29 | 2020-05-29 | |
| US63/031,686 | 2020-05-29 | ||
| PCT/IB2020/058483 WO2021048822A1 (en) | 2019-09-13 | 2020-09-12 | Tak-925 for use in treating narcolepsy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022547711A JP2022547711A (ja) | 2022-11-15 |
| JP2022547711A5 true JP2022547711A5 (https=) | 2023-09-20 |
Family
ID=72560858
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022516270A Pending JP2022547711A (ja) | 2019-09-13 | 2020-09-12 | ナルコレプシーの治療に使用するためのｔａｋ－９２５ |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20220339143A1 (https=) |
| EP (1) | EP4028004A1 (https=) |
| JP (1) | JP2022547711A (https=) |
| KR (1) | KR20220062012A (https=) |
| CN (1) | CN114980892A (https=) |
| AU (1) | AU2020346456A1 (https=) |
| BR (1) | BR112022004587A2 (https=) |
| CA (1) | CA3154321A1 (https=) |
| CO (1) | CO2022004596A2 (https=) |
| MX (1) | MX2022003018A (https=) |
| WO (1) | WO2021048822A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112022004576A2 (pt) * | 2019-09-13 | 2022-06-14 | Takeda Pharmaceuticals Co | Métodos para diminuir ou tratar sonolência excessiva, tratar narcolepsia tipo 2 ou hipersonia idiopática, tratar distúrbio de trabalho de turno, aumentar latência de sono em manutenção de teste de insônia, melhorar classificação de escaça de sonolência de karolinska, diminuir ou melhorar sonolência subjetiva, aumentar insônia ou diminuir sonolência excessiva, melhorar classificação de escala de sonolência epworth, tratar narcolepsia tipo 2, diminuir ou tratar sonolência diurna excessiva, e, composição farmacêutica |
| MX2022008392A (es) | 2020-01-10 | 2022-08-08 | Takeda Pharmaceuticals Co | Metodo para mejorar la farmacocinetica o aumentar la concentracion de plasma de 3-((metilsulfonil)amino)-2-(((4-fenilci clohexil)oxi)metil)piperidina-1-carboxilato de metilo o una sal del mismo con un inhibidor de citocromo p450. |
| US12503475B2 (en) | 2020-09-03 | 2025-12-23 | Centessa Pharmaceuticals (Uk) Limited | Bicyclic-heterocycle derivatives and their uses as orexin-2 receptor agonists |
| BR112023020104A2 (pt) * | 2021-04-02 | 2023-11-14 | Takeda Pharmaceuticals Co | Métodos para recuperação pós-operação, para facilitar a recuperação ou reduzir o tempo de recuperação da anestesia, para prevenir ou tratar distúrbios/depressão respiratória pós-operatória ou distúrbios/depressão respiratória induzida por opioides, sedação pós-operatória ou sedação induzida por opioides e para reduzir um efeito colateral de opioides |
| CN119677753A (zh) | 2022-04-22 | 2025-03-21 | 帝人制药株式会社 | 氧杂氮杂环庚三烯衍生物 |
| AR130709A1 (es) | 2022-10-07 | 2025-01-08 | Kissei Pharmaceutical | Compuesto de ciclopentano |
| WO2024095158A1 (en) * | 2022-10-31 | 2024-05-10 | Takeda Pharmaceutical Company Limited | Dosing of orexin type 2 receptor agonists |
| TW202535890A (zh) | 2023-10-20 | 2025-09-16 | 日商帝人製藥股份有限公司 | 氧氮呯衍生物之結晶或其溶劑合物之結晶 |
| WO2025124698A1 (en) | 2023-12-12 | 2025-06-19 | Idorsia Pharmaceuticals Ltd | Aryl sulfone and sulfanone derivatives as orexin receptor modulators |
| TW202542165A (zh) | 2023-12-19 | 2025-11-01 | 瑞士商愛杜西亞製藥有限公司 | 大環食慾素激動劑 |
| WO2025229493A1 (en) * | 2024-04-29 | 2025-11-06 | Takeda Pharmaceutical Company Limited | Dosing of orexin type 2 receptor agonists |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5854204A (en) | 1995-03-14 | 1998-12-29 | Praecis Pharmaceuticals, Inc. | Aβ peptides that modulate β-amyloid aggregation |
| JP2001500852A (ja) | 1996-08-27 | 2001-01-23 | プレーシス ファーマスーティカルズ インコーポレイテッド | Ｄ―アミノ酸を含むβ―アミロイドペプチド凝集のモジュレーター |
| CA2374610A1 (en) | 1999-06-28 | 2001-01-04 | Jordan J. N. Tang | Catalytically active recombinant memapsin and methods of use thereof |
| ES2843952T3 (es) * | 2014-10-23 | 2021-07-21 | Eisai R&D Man Co Ltd | Composiciones para tratar el insomnio |
| US10022355B2 (en) * | 2015-06-12 | 2018-07-17 | Axovant Sciences Gmbh | Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of REM sleep behavior disorder |
| PL3411358T3 (pl) * | 2016-02-04 | 2022-02-28 | Takeda Pharmaceutical Company Limited | Podstawiony związek piperydynowy i jego zastosowanie |
-
2020
- 2020-09-12 CA CA3154321A patent/CA3154321A1/en active Pending
- 2020-09-12 JP JP2022516270A patent/JP2022547711A/ja active Pending
- 2020-09-12 WO PCT/IB2020/058483 patent/WO2021048822A1/en not_active Ceased
- 2020-09-12 CN CN202080073637.7A patent/CN114980892A/zh active Pending
- 2020-09-12 BR BR112022004587A patent/BR112022004587A2/pt unknown
- 2020-09-12 AU AU2020346456A patent/AU2020346456A1/en not_active Abandoned
- 2020-09-12 KR KR1020227011013A patent/KR20220062012A/ko active Pending
- 2020-09-12 EP EP20775077.9A patent/EP4028004A1/en not_active Withdrawn
- 2020-09-12 MX MX2022003018A patent/MX2022003018A/es unknown
- 2020-09-12 US US17/642,331 patent/US20220339143A1/en not_active Abandoned
-
2022
- 2022-04-11 CO CONC2022/0004596A patent/CO2022004596A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022547711A5 (https=) | ||
| JP2022547604A5 (https=) | ||
| AU2002316582B2 (en) | Oral administration of 6-hydroxy-oxymorphone for use as an analgesic | |
| KR102874891B1 (ko) | 수면 무호흡증을 치료하기 위한 방법 및 조성물 | |
| RU2488392C2 (ru) | Лечение агонистом мелатонина | |
| US20080021074A1 (en) | Pharmaceutical Compositions and Related Methods of Treatment | |
| JP2003503450A5 (https=) | ||
| MX2010013503A (es) | Composicion de topiramato/fentermina de baja dosis y metodos de uso de la misma. | |
| JP7705348B2 (ja) | 睡眠時無呼吸を治療するための方法および組成物 | |
| EP1154795B1 (en) | Means for treating and diagnosing restless legs syndrome | |
| EP0923370A2 (en) | Method of treating and diagnosing sleep disordered breathing and means for carrying out the method | |
| CA3156009A1 (en) | POLYTHERAPY WITH CGRP ANTAGONISTS | |
| US20250114321A1 (en) | Methods and compositions for treating sleep apnea | |
| EP3132803B1 (en) | Preventive or therapeutic agent for pain associated with herpes zoster in acute phase | |
| RU2004131214A (ru) | Способы лечения когнитивных расстройств | |
| TW200946108A (en) | Use of dronedarone or a pharmaceutically acceptable salt thereof, for the preparation of a medicament for regulating the potassium level in the blood | |
| JP2011512399A (ja) | 卵巣癌を治療するための、パクリタキセルを含む配合剤 | |
| JPWO2004060400A1 (ja) | 上皮成長因子受容体を分子標的とする抗精神病薬 | |
| US6545057B2 (en) | Tricyclic antidepressants and their analogues as long-acting local anesthetics and analgesics | |
| KR20010024548A (ko) | 질병관련 또는 약물유발 운동장해의 치료방법 | |
| US6489356B2 (en) | Method for treating pain in humans | |
| JP3227578B2 (ja) | 睡眠誘起性無呼吸症治療剤 | |
| US5407953A (en) | Treating apnea/hypopnea/snoring in humans | |
| JPH08504203A (ja) | パーキンソン病およびその進行を治療する薬剤の製造のためのイダゾキサンおよびその誘導体の使用 | |
| RU2605283C2 (ru) | Фармацевтическая композиция для лечения зависимости у людей |